See Our Current Investments

Target Fast Moving Stocks

OFF | ON
home
about catalysts FAQ

CLINICAL TRIALS

NTI Begins Autism Clinical Trials for Unique Cannabis Strain

nextinvestors 05/05/2021

NTI Begins Autism Clinical Trials for Unique Cannabis Strain

Neurotech International Ltd (ASX: NTI) has begun its first clinical trials on children aged between 5 and 17 years with Autism Spectrum Disorder (ASD) for its unique cannabis strain.

read article Neurotech International (ASX:NTI)

These share price catalyst events take months and years of work and preparation...
Why invest in stock when there is still months and months before any share price movement can happen.

Get email alerts as soon as new articles are released.

Thanks for subscribing!

X